Natural course of moderate cardiac allograft rejection (Internal Society for Heart Transplantation Grade 2) early and late after transplantation

Circulation

Volumn 94, Issue 6, 1996, Pages 1334-1338

  Brunner La Rocca, Hans P ^a   Sütsch, Gabor ^a   Schneider, Jakob ^a   Follath, Ferenc ^a   Kiowski, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

biopsy; rejection; transplantation

Indexed keywords

CYCLOSPORIN;

ADOLESCENT; ADULT; ARTICLE; DISEASE COURSE; FEMALE; GRAFT REJECTION; HEART GRAFT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 0029846904     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.94.6.1334     Document Type: Article

References (34)

1. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group - The Inter-national Society for Heart Transplantation. J Heart Transplant. 1990;9:587-593.
2. Gallo P, Grillo LR, di Gioia C, Coppola L, Franscalanci P, d'Amati G. Working formulation nomenclature in the diagnosis of heart transplant pathology: a retrospective evaluation of 1037 endomyocardial biopsies. Cardiovasc Pathol. 1992;1:87-92.
3. Gleeson MP, Kobashigawa J, Stevenson LW, Moriguchi J, Kawata N, Hamilton MA, Hage A, Drinkwater D, Laks H. The natural history of focal moderate rejection in orthotopic heart transplant recipients. J Am Coll Cardiol. 1994;23:483A. Abstract.
4. Lloveras JJ, Escourrou G, Delisle MB, Fournial G, Cerene A, Bassanetti I, Durand D. Evolution of untreated mild rejection in heart transplant recipients. J Heart Lung Transplant. 1992; 11:751-756.
5. Winters GL, Loh E, Schoen FJ. Natural history of focal moderate cardiac allograft rejection: is treatment warranted? Circulation. 1995;91:1975-1980.
6. Bolling SF, Putman JB, Abrams GD, McKay AM, Deeb GM. Hemodynamic versus biopsy findings during cardiac transplant rejection. Ann Thorac Surg. 1991;51:52-55.
7. Fishbein MC, Bell G, Lones MA, Czer LS, Miller JM, Harasty D, Trento A. Grade 2 cellular heart rejection: does it exist? J Heart Lung Transplant. 1994;13:1051-1057.
8. Billingham ME. Cardiac transplantation. In: Sale GE, ed. The Pathology of Organ Transplantation. Boston, Mass: Butterworth Publishers; 1990:133.
9. Miller LW, Schlant RC, Kobashigawa J, Kubo SH, Renlund DG. 24th Bethesda Conference: cardiac transplantation - Task Force 5: complications. J Am Coll Cardiol. 1993;22:41-54.
10. McAllister HA. Histologic grading of cardiac allograft rejection: a quantitative approach. J Heart Transplant. 1990;9:277-282.
11. Spratt P, Sivathasan C, Macdonald P, Keogh A, Chang V. Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation. J Heart Lung Transplant. 1991;10:912-914.
12. Kirklin JK, Naftel DC, Bourge RC, White-Williams C, Caulfield JB, Tarkka MR, Holman WL, Zorn GL Jr. Rejection after cardiac transplantation: a time-related risk factor analysis. Circulation. 1992; 86(suppl II):II-236-II-241.
13. Kobashigawa J, Kirklin JK, Naftel DC, Bourge RC, Ventura HO, Mohanty PK, Cintron GB, Bhat G. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant. 1993;12:355-366.
14. Costanzo-Nordin MR, Winters GL, Fisher SG, O'Sullivan J, Heroux AL, Kao W, Mullen GM, Johnson MR. Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens. J Heart Lung Transplant. 1993;12:741-747.
15. Pardo Mindan FJ, Lozano MD. 'Quilty effect' in heart transplantation: is it related to acute rejection? J Heart Lung Transplant. 1991;10:937-941
16. Joshi A, Masek MA, Brown BW Jr, Weiss LM, Billingham ME. 'Quilty' revisited; a 10-year perspective. Hum Pathol. 1995;26:547-557.
17. Winters GL, Costanzo-Nordin MR. Pathological findings in 2300 consecutive endomyocardial biopsies. Mod Pathol. 1991;4:441-448.
18. Tazelaar HD. Spectrum and diagnosis of myocardial rejection. Cardiol Clin. 1990;8:119-139.
19. Zerbe TR, Kormos R, Arena V, Griffith B, Hardesty R, Duquesnoy R. Histocompatibility and other rejection risk factors in cardiac transplantation. Transplant Proc. 1991;23:1155-1156.
20. Jarcho J, Naftel DC, Shroyer TW, Kirklin JK, Bourge RC, Barr ML, Pitts DG, Starling RC. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study - the Cardiac Trans-plant Research Database Group. J Heart Lung Transplant. 1994;13:583-595.
21. Foerster A, Abdelnoor M, Geiran O, Lindberg H, Simonsen S, Thorsby E, Froysaker T. Morbidity risk factors in human cardiac transplantation: histocompatibility and protracted graft ischemia entail high risk of rejection and infection. Scand J Thorac Cardiovasc Surg. 1992;26:169-176.
22. Hendriks GF, van Steenberge EP, Schreuder GM, Wenting GJ, Mochtar B, Bos E, Simoons ML, Balk AH, Laird Meeter K, Essed CE. Treatment with cyclosporine and risks of graft rejection in male kidney and heart transplant recipients with non-O blood. BMJ. 1988;297:888-890.
23. Nakatani T, Aida H, Frazier OH, Marcris MP. Effect of ABO blood type on survival of heart transplant patients treated with cyclosporine. J Heart Transplant. 1989;8:27-33.
24. Grattan MT, Moreno Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989;261:3561-3566.
25. Esmore D, Keogh A, Spratt P, Jones B, Chang V. Heart transplantation in females. J Heart Lung Transplant. 1991;10:335-341.
26. Laufer G, Laczkovics A, Wollenek G, Buxbaum P, Seitelberger R, Holzinger C, Horvat R, Havel M, Wolner E. The progression of mild acute cardiac rejection evaluated by risk factor analysis: the impact of maintenance steroids and serum creatinine. Transplantation. 1991;51:184-189.
27. Waser M, Maggiorini M, Binswanger U, Keusch G, Carrel T, von Segesser L, Gallino A, Turina M. Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients, 7 Heart Lung Transplant. 1993;12:846-850.
28. Kormos RL, Armitage JM, Hardesty RL, Hattler BG, del Nido P, Marrone GC, Lee A, Uretsky BF, Murali S, Griffith BP. Cardiac transplantation at the University of Pittsburgh: 1980 to 1991. Clin Transpl. 1991;5:87-95.
29. Hausen B, Demertzis S, Schafers HJ, Wahlers TH. Wagenbreth I, Haverich A. The impact of early postoperative cyclosporine serum levels on the incidence of cardiac allograft rejection. Eur J Cardiothorac Surg. 1993;7:257-262.
30. Hausen B, Demertzis S, Rohde R, Albes JM, Schafers HJ, Borst HG. Low-dose cyclosporine therapy in triple-drug immunosuppression for heart transplant recipients. Ann Thorac Surg. 1994;58:999-1004.
31. Jennison SH, Wesp AG, McBride LR, Miller LW. Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation. Transplant Proc. 1994;26:2732-2735.
32. Kobashigawa J, Stevenson LW, Moriguchi J, Westlake C, Wilmarth J, Kawata N, Chuck C, Lewis W, Drinkwater D, Laks H. Randomized study of high dose oral cyclosporine therapy for mild acute cardiac rejection. J Heart Transplant. 1989;8:53-58.
33. Gallo P, Bardoldi G, Thiene G, Agozzino L, Arbustini E, Bartoloni G, Bonacina E, Bosman C, Catani G, Cocco P. When and why do heart transplant recipients die? A 7 year experience of 1068 cardiac transplants. Virchows Arch A Pathol Anat Histopathol. 1993;422: 453-458.
34. Anguita M, López Rubio F, Arizón JM, Latre JM, Casares J, López Granados A, Mesa D, Giménez D, Torres F, Concha M, Vallés F. Repetitive nontreated episodes of grade 1B or 2 acute rejection impair long-term cardiac graft function. J Heart Lung Transplant. 1995;14:452-460.